EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2

Koen Van Laere, Andrea Varrone, Jan Booij, Thierry Vander Borght, Flavio Nobili, Özlem L. Kapucu, Zuzana Walker, Kjell Någren, Klaus Tatsch, Jacques Darcourt

Research output: Contribution to journalReview article

31 Citations (Scopus)

Abstract

The guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The aims of the guidelines are to assist nuclear medicine practitioners in making recommendations, performing, interpreting and reporting the results of clinical dopamine D2 receptor SPECT or PET studies, and to achieve a high quality standard of dopamine D2 receptor imaging, which will increase the impact of this technique in neurological practice. The present document is an update of the first guidelines for SPECT using D2 receptor ligands labelled with 123I [1] and was guided by the views of the Society of Nuclear Medicine Brain Imaging Council [2], and the individual experience of experts in European countries. The guidelines intend to present information specifically adapted to European practice. The information provided should be taken in the context of local conditions and regulations.

Original languageEnglish
Pages (from-to)434-442
Number of pages9
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume37
Issue number2
DOIs
Publication statusPublished - Feb 1 2010

Fingerprint

Dopamine D2 Receptors
Single-Photon Emission-Computed Tomography
Synaptic Transmission
Guidelines
Ligands
Brain
Neuroimaging
Nuclear Medicine

Keywords

  • Brain
  • D2 receptor
  • Dopamine
  • Parkinsonism
  • PET
  • SPECT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2. / Van Laere, Koen; Varrone, Andrea; Booij, Jan; Vander Borght, Thierry; Nobili, Flavio; Kapucu, Özlem L.; Walker, Zuzana; Någren, Kjell; Tatsch, Klaus; Darcourt, Jacques.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 37, No. 2, 01.02.2010, p. 434-442.

Research output: Contribution to journalReview article

Van Laere, K, Varrone, A, Booij, J, Vander Borght, T, Nobili, F, Kapucu, ÖL, Walker, Z, Någren, K, Tatsch, K & Darcourt, J 2010, 'EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2', European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 2, pp. 434-442. https://doi.org/10.1007/s00259-009-1265-z
Van Laere, Koen ; Varrone, Andrea ; Booij, Jan ; Vander Borght, Thierry ; Nobili, Flavio ; Kapucu, Özlem L. ; Walker, Zuzana ; Någren, Kjell ; Tatsch, Klaus ; Darcourt, Jacques. / EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2. In: European Journal of Nuclear Medicine and Molecular Imaging. 2010 ; Vol. 37, No. 2. pp. 434-442.
@article{047720cb3b9b4712a981ca08f9c2700b,
title = "EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2",
abstract = "The guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The aims of the guidelines are to assist nuclear medicine practitioners in making recommendations, performing, interpreting and reporting the results of clinical dopamine D2 receptor SPECT or PET studies, and to achieve a high quality standard of dopamine D2 receptor imaging, which will increase the impact of this technique in neurological practice. The present document is an update of the first guidelines for SPECT using D2 receptor ligands labelled with 123I [1] and was guided by the views of the Society of Nuclear Medicine Brain Imaging Council [2], and the individual experience of experts in European countries. The guidelines intend to present information specifically adapted to European practice. The information provided should be taken in the context of local conditions and regulations.",
keywords = "Brain, D2 receptor, Dopamine, Parkinsonism, PET, SPECT",
author = "{Van Laere}, Koen and Andrea Varrone and Jan Booij and {Vander Borght}, Thierry and Flavio Nobili and Kapucu, {{\"O}zlem L.} and Zuzana Walker and Kjell N{\aa}gren and Klaus Tatsch and Jacques Darcourt",
year = "2010",
month = "2",
day = "1",
doi = "10.1007/s00259-009-1265-z",
language = "English",
volume = "37",
pages = "434--442",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Berlin Heidelberg",
number = "2",

}

TY - JOUR

T1 - EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2

AU - Van Laere, Koen

AU - Varrone, Andrea

AU - Booij, Jan

AU - Vander Borght, Thierry

AU - Nobili, Flavio

AU - Kapucu, Özlem L.

AU - Walker, Zuzana

AU - Någren, Kjell

AU - Tatsch, Klaus

AU - Darcourt, Jacques

PY - 2010/2/1

Y1 - 2010/2/1

N2 - The guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The aims of the guidelines are to assist nuclear medicine practitioners in making recommendations, performing, interpreting and reporting the results of clinical dopamine D2 receptor SPECT or PET studies, and to achieve a high quality standard of dopamine D2 receptor imaging, which will increase the impact of this technique in neurological practice. The present document is an update of the first guidelines for SPECT using D2 receptor ligands labelled with 123I [1] and was guided by the views of the Society of Nuclear Medicine Brain Imaging Council [2], and the individual experience of experts in European countries. The guidelines intend to present information specifically adapted to European practice. The information provided should be taken in the context of local conditions and regulations.

AB - The guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The aims of the guidelines are to assist nuclear medicine practitioners in making recommendations, performing, interpreting and reporting the results of clinical dopamine D2 receptor SPECT or PET studies, and to achieve a high quality standard of dopamine D2 receptor imaging, which will increase the impact of this technique in neurological practice. The present document is an update of the first guidelines for SPECT using D2 receptor ligands labelled with 123I [1] and was guided by the views of the Society of Nuclear Medicine Brain Imaging Council [2], and the individual experience of experts in European countries. The guidelines intend to present information specifically adapted to European practice. The information provided should be taken in the context of local conditions and regulations.

KW - Brain

KW - D2 receptor

KW - Dopamine

KW - Parkinsonism

KW - PET

KW - SPECT

UR - http://www.scopus.com/inward/record.url?scp=77949267716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949267716&partnerID=8YFLogxK

U2 - 10.1007/s00259-009-1265-z

DO - 10.1007/s00259-009-1265-z

M3 - Review article

VL - 37

SP - 434

EP - 442

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 2

ER -